Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).

被引：0
|
作者：
Tomas, IF [1 ]
Steegman, IL [1 ]
Requena, MI [1 ]
Soria, VGG [1 ]
FernandezRanada, IM [1 ]
机构：
[1] UNIV MADRID,HOSP PRINCESA,DEPT HAEMATOL,MADRID,SPAIN
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3859 / 3859
页数：1
相关论文
共 50 条
  • [41] Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation
    Steegmann, JL
    Casado, LF
    Tomás, JF
    Sanz-Rodríguez, C
    Granados, E
    de la Cámara, R
    Alegre, A
    Vázquez, L
    Ferro, MT
    Figuera, A
    Arranz, L
    Fernández-Rañada, JM
    BONE MARROW TRANSPLANTATION, 1999, 23 (05) : 483 - 488
  • [42] The prognostic relevance of HLA phenotype in allogeneic bone marrow transplantation in Turkish patients with chronic myelogenous leukemia (CML).
    Ilhan, O
    Ozcan, M
    Beksac, M
    Koc, H
    Akan, H
    Kutlay, S
    Dalva, K
    Gurman, G
    Arslan, O
    Arat, M
    Dilek, I
    Konuk, N
    Uysal, A
    BLOOD, 1996, 88 (10) : 3825 - 3825
  • [43] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN ACUTE CRISIS
    NAITO, K
    YAMADA, K
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 593 - 593
  • [44] Treatment of chronic myelogenous leukemia (CML) with allogeneic bone marrow transplantation after preparation with BuCy2.
    Copelan, EA
    Biggs, JC
    Szer, J
    Crilley, P
    Atkinson, K
    Avalos, B
    Topolsky, D
    Penza, SL
    Elder, PJ
    Bulova, SL
    Brodsky, I
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 670 - 670
  • [45] IMPACT OF DISEASE DURATION AND PRIOR TREATMENT ON OUTCOME OF BONE-MARROW TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    GOLDMAN, JM
    MCGLAVE, P
    SZYDLO, R
    GALE, RP
    HOROWITZ, MM
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 830 - 830
  • [46] THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    MARMONT, AM
    LEUKEMIA & LYMPHOMA, 1993, 11 : 221 - 226
  • [47] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) - IMPROVED RESULTS BY A NEW IMMUNOPROPHYLAXIS
    GRAEVEN, U
    BEELEN, DW
    QUABECK, K
    SAYER, HG
    SCHAEFER, UW
    BLUT, 1988, 57 (04): : 198 - 198
  • [48] Prior therapy with interferon-alpha has a negative impact on outcome after allogeneic bone marrow transplantation with identical sibling donnor for chronic myeloid leukemia in first chronic phase
    Arnaud, P
    Thomas, X
    Raus, N
    Houot, R
    Bilger, K
    Thiebaut, A
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S142 - S142
  • [49] BONE-MARROW TRANSPLANTATION (BMT) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML)
    HINTERBERGER, W
    FISCHER, M
    KALLINGER, W
    HAYEKROSENMAYR, A
    HOCKER, P
    ALTH, G
    KOLBABEK, H
    HAAS, O
    BETTELHEIM, P
    NEUMANN, E
    NIESSNER, H
    LECHNER, K
    DEUTSCH, E
    BLUT, 1984, 49 (03): : 291 - 291
  • [50] Treatment of Ph+ chronic myelogenous leukemia (CML) with interferon alfa 2B R(IFN)
    Murro, H
    Bezares, R
    Longordo, F
    Fuchs, CR
    Saidon, G
    Diaz, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 813 - 813
12345